ENZY Enzymotec Ltd. - Ordinary Shares (delisted)

GW Pharmaceuticals plc (GWPH) was a big mover last session, as its shares rose nearly 14% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend for the company since Apr 3, as the stock is now trading above the volatile price range of $44.00 to $60.86.

In the last 30 days, the company has not seen any estimate revision and the Zacks Consensus Estimate also remained unchanged. However, yesterday’s price action is encouraging, so make sure to keep a close watch on this firm in the near future.

GW Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked medical stocks include Edwards Lifesciences Corp. (EW), Enzymotec Ltd. (ENZY) and Venaxis, Inc. (APPY). While Edwards Lifesciences and Venaxis carry a Zacks Rank #2 (Buy), Enzymotec sports a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
 
VENAXIS INC (APPY): Get Free Report
 
ENZYMOTEC LTD (ENZY): Free Stock Analysis Report
 
EDWARDS LIFESCI (EW): Free Stock Analysis Report
 
GW PHARMA-ADR (GWPH): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research